Jun 03, 2021 / 02:00PM GMT
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity Analyst
Well, thank you, and good morning, and welcome to another great session here at the Jefferies Global Healthcare Conference. Obviously, very pleased to have with us here the CEO of Moderna, Stephane Bancel. Thank you for joining with us. I know it's crazy and busy times for you but certainly exciting times and certainly a lot to talk about. So thanks for being here with us.
Stephane Bancel - Moderna, Inc. - CEO & Director
Thank you, Michael, for having me.
Questions and Answers:
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity AnalystLet me just start first by talking -- asking you about your perspective on the 2021 outlook for COVID vaccines for Moderna and bridge that into your thoughts and visibility into 2022. This seems to be a big debate, but I'd love to hear your perspective as how that evolves.
Stephane Bancel - Moderna, Inc. - CEO & Director
Sure. So '21, from a